COTXF (Coiled Therapeutics) EPS (Diluted): $-0.29 (TTM As of Dec. 2025)


COTXF Coiled Therapeutics PLC COTXF
21 GF Score
Price $0.15
! 4 Warning Signs
View Full Analysis

What is Coiled Therapeutics EPS (Diluted)?

Coiled Therapeutics COTXF 21 EPS (Diluted) is $-0.29 as of Dec. 2025. GuruFocus rates COTXF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Coiled Therapeutics's Earnings per Share (Diluted) for the six months ended in Dec. 2025 was $-0.25. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.29.

Coiled Therapeutics's EPS (Basic) for the six months ended in Dec. 2025 was $-0.25. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.29.

Coiled Therapeutics's EPS without NRI for the six months ended in Dec. 2025 was $-0.25. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.29.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Coiled Therapeutics  (OTCPK:COTXF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Coiled Therapeutics EPS (Diluted) Related Terms

Coiled Therapeutics EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Coiled Therapeutics's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coiled Therapeutics EPS (Diluted) Chart

Coiled Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Diluted)
0.00 -0.19 -0.17 -0.10 -0.29

Coiled Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 -0.06 -0.04 -0.05 -0.25

COTXF vs VRTX, REGN, ALNY: EPS (Diluted) Comparison

For the Biotechnology subindustry, Coiled Therapeutics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coiled Therapeutics PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coiled Therapeutics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Coiled Therapeutics's PE Ratio falls into.


COTXF
21GF Score
Coiled Therapeutics PLC COTXF
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coiled Therapeutics EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Coiled Therapeutics's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as

Diluted EPS (A: Dec. 2025 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.501-0)/15.356
=-0.29

Coiled Therapeutics's Diluted EPS for the quarter that ended in Dec. 2025 is calculated as

Diluted EPS (Q: Dec. 2025 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.845-0)/15.951
=-0.24

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $-0.29 mean?
Coiled Therapeutics (COTXF) has a EPS (Diluted) of $-0.29 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Coiled Therapeutics and its competitors.
Is Coiled Therapeutics' EPS (Diluted) too high?
Coiled Therapeutics' current EPS (Diluted) is $-0.29. Overall, Coiled Therapeutics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Coiled Therapeutics' EPS (Diluted) compare to VRTX and REGN?
Coiled Therapeutics' EPS (Diluted) of $-0.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Coiled Therapeutics and its competitors. Coiled Therapeutics's current EPS (Diluted) is $-0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coiled Therapeutics stock overvalued right now?
Coiled Therapeutics (COTXF) has a current EPS (Diluted) of $-0.29. The current EPS (Diluted) is $-0.29. Coiled Therapeutics' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Coiled Therapeutics (COTXF), the current EPS (Diluted) is $-0.29 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coiled Therapeutics Business Description

Other Exchanges COIL:UK0AG0:Germany
Address 85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.
21GF Score

Get the complete analysis for COTXF

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price